Meet the Sanguina founders who are passionate about health and wellness at your fingertips.
Erika A. Tyburski, BS
Chief Executive Officer
Erika graduated from Georgia Tech with her degree in biomedical engineering in 2012. Since graduating, she has garnered both technical and entrepreneurial skills through hands-on execution of preclinical and clinical assessments, regulatory studies and strategies, quality management systems development, company operations, funding management, and team expansion. Erika has experienced iron deficiency anemia throughout her life, and has dedicated her post-graduate career to creating solutions for key issues around anemia—namely, that screenings are typically only conducted in clinical settings with few options for easy at-home testing. She co-founded Sanguina as a start-up out of Georgia Tech and Emory University and leads our team focus: The development and launch of at-home wellness tools like AnemoCheck, a color-based disposable screening tool for anemia; a revolutionary new, non-invasive mobile app for screening anemia; and other tools that have the potential to make a significant impact on health and wellness.
Wilbur A. Lam, MD, Ph. D.
Chief Medical Officer
Wilbur is a bioengineer and clinical pediatric hematologist/oncologist who is an Associate Professor of Biomedical Engineering and Pediatrics at Emory University School of Medicine and Georgia Tech; as well as an attending physician in the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta. Dr. Lam leads an interdisciplinary laboratory dedicated to developing innovative and inexpensive diagnostics for hematologic diseases. Wilbur serves as Chief Medical Officer of Sanguina and continues to supervise the technical development of the AnemoCheck platform.
“My personal goal is to create and provide access to solutions that enable, educate, and empower people with information about their health.”
—Erika Tyburski, Co-Founder
Robert Mannino, Ph.D.
Chief Technology Officer
Rob earned his PhD in biomedical engineering at the Georgia Institute of Technology and Emory University in 2018. Rob suffers from beta thalassemia major, a genetic blood disorder that causes him to be severely anemic and requires that he receive regular blood transfusions. His experience living with this disease motivates him to develop diagnostic technologies for anemia that can improve quality of life. Rob has extensive experience in computational analysis and leads development of our AnemoCheck Mobile product. Along with Erika, Rob was named to the 2020 Forbes 30 Under 30 Healthcare list for his work on this innovative technology. Rob serves as the Chief Technology Officer of Sanguina and is committed to making it easier for people to maintain healthy lifestyles through technology.
Chief Financial Officer
Rene is an entrepreneur with over 18 years of startup experience in numerous companies. During this time, he has played senior roles in finance, marketing, scaling operations, and business development. Rene has been instrumental in establishing and scaling early-stage companies in various industries. Rene received both his undergraduate degree and MBA at MIT. He has joined Sanguina as CFO focused on the financial model, funding and business development.
“As I have grown up with beta thalassemia major, I have experienced firsthand the impact that improvements in medical device technology can have on the lives of patients. This experience has motivated me to design and develop devices that can improve the quality of life of patients like myself.”
—Robert Mannino, Chief Technology Officer
Tom S. Stribling
Advisor & Co-Founder
Tom has over twenty-five years of experience in the health care industry, and companies he led have consistently reached successful and profitable liquidity through sale to larger corporations. Prior to Sanguina, he started three other companies and joined three companies in turn-around situations. All of these experiences were at the President and/or CEO level.
Andrew Lyon, Ph.D.
Chief Scientific Officer
Andrew is currently Professor of Chemistry and Founding Dean of the Fowler School of Engineering at Chapman University in Orange, CA. He was formerly Dean of the College of Science at Chapman, and served as Chair of Chemistry and Biochemistry at Georgia Tech before his move to the west coast. Andrew holds seven issued U.S. patents and has extensive experience in bioanalytical chemistry, materials science, biomaterials, and in vitro diagnostics. He currently serves as Chief Scientific Officer of Sanguina.